CG
KLRS

Cutler Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Cutler Group’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-78
Closed -$14K – 2479
2022
Q3 		$14K Sell
78
-39
-33% -$7K ﹤0.01% 1295
2022
Q2 		$10K Buy
+117
New +$10K ﹤0.01% 1388
2020
Q4 		– Sell
-22
Closed -$13K – 2486
2020
Q3 		$13K Buy
+22
New +$13K ﹤0.01% 1257